RESMED INC. COMMON STOCK

ResMed to Report Second Quarter Fiscal 2023 Earnings on January 26, 2023

12 Jan 2023 09:00:01 By Nasdaq GlobeNewswire

ResMed Announces Participation in the 41st Annual J.P. Morgan Healthcare Conference

02 Jan 2023 16:05:00 By Nasdaq GlobeNewswire

ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions

22 Nov 2022 09:00:30 By Nasdaq GlobeNewswire

ResMed Opens Manufacturing Centre in Singapore, Expanding Manufacturing Footprint to Support Growth, Development, and Production of Digital Health Solutions

16 Nov 2022 18:30:00 By Nasdaq GlobeNewswire

ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023

27 Oct 2022 16:05:01 By Nasdaq GlobeNewswire

ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022

13 Oct 2022 16:05:00 By Nasdaq GlobeNewswire

ResMed Announces Participation in the Bank of America Global Healthcare Conference

07 Sep 2022 09:00:01 By Nasdaq GlobeNewswire

ResMed Announces Participation in the 20th Annual Morgan Stanley Global Healthcare Conference

06 Sep 2022 09:00:01 By Nasdaq GlobeNewswire

Over 480 Million People Estimated to Have COPD, World’s Third Deadliest Disease, ResMed Study Reports

04 Sep 2022 08:00:00 By Nasdaq GlobeNewswire

ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2022

11 Aug 2022 16:05:04 By Nasdaq GlobeNewswire

ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio

02 Aug 2022 05:00:00 By Nasdaq GlobeNewswire

ResMed to Report Fourth Quarter Fiscal 2022 Earnings on August 11, 2022

14 Jul 2022 16:05:00 By Nasdaq GlobeNewswire

ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions

14 Jun 2022 02:05:00 By Nasdaq GlobeNewswire

ResMed Announces Participation in the 43rd Annual Goldman Sachs Global Healthcare Conference

07 Jun 2022 09:00:01 By Nasdaq GlobeNewswire

ResMed Announces Participation in the 42nd Annual William Blair Growth Stock Conference

01 Jun 2022 09:00:02 By Nasdaq GlobeNewswire

ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference

25 May 2022 09:00:01 By Nasdaq GlobeNewswire

Even 2 Hours of PAP Therapy per Night Benefits Sleep Apnea Sufferers: ResMed Study

18 May 2022 16:05:00 By Nasdaq GlobeNewswire

ResMed Announces Leadership Change

05 May 2022 16:05:01 By Nasdaq GlobeNewswire

ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022

28 Apr 2022 16:05:02 By Nasdaq GlobeNewswire

ResMed Announces Participation in the 24th Annual Macquarie Australia Conference

27 Apr 2022 16:05:00 By Nasdaq GlobeNewswire